Goldman Sachs Upgrades Coventry Health Care (CVH) to Buy, Sees 27% Upside
Tweet
Share
E-mailGet Alerts CVH Hot Sheet
Price: $49.99 --0%
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs upgraded Coventry Health Care (NYSE: CVH) from Neutral to Buy with a price target of $42 (up from $35), suggesting 27% upside.
The firm said the upgrade reflects potential upside as the company builds a larger footprint in public sector managed care (Medicare, Medicaid, and dual-eligibles). Shares have upside on potential market "re-rating."
For an analyst ratings summary and ratings history on Coventry Health Care click here. For more ratings news on Coventry Health Care click here.
Shares of Coventry Health Care closed at $32.21 yesterday.
The firm said the upgrade reflects potential upside as the company builds a larger footprint in public sector managed care (Medicare, Medicaid, and dual-eligibles). Shares have upside on potential market "re-rating."
For an analyst ratings summary and ratings history on Coventry Health Care click here. For more ratings news on Coventry Health Care click here.
Shares of Coventry Health Care closed at $32.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
